Case guide

Novo Nordisk: Check the Drug and Claim Records

Checking a claim involving Novo Nordisk? Keep the exact drug name, form and dates.

See If You Qualify

Free · No obligation · About 2 minutes

Updated Oct 4, 202614 sources

This may apply to you if

  • Tell the lawyer the exact drug you used and when you used it.
  • Bring the gut diagnosis and test results in your medical chart.
  • Describe symptoms before and after the drug, including other health problems.

What the public record says

These are cited sources. Their inclusion does not imply that they endorse People’s Justice or reviewed this page.

Karen Spencer Marston · United States District Court for the Eastern District of Pennsylvania · United States District Judge

Finding: The August 28, 2026 order set a September 14–18 evidence hearing in the gut case group. A hearing date is not a verdict or a personal payment date.

GI evidence-hearing scheduling order, Document 881 (opens in a new tab) · Aug 28, 2026 · Checked Oct 3, 2026

Mohit Sodhi · Faculty of Medicine, University of British Columbia · First-listed study author

Finding: The 2023 JAMA claims-record study found links between semaglutide or liraglutide use and some gut diagnoses. The observed links do not prove the cause of one person’s illness.

Sodhi original gastrointestinal cohort study (opens in a new tab) · Oct 5, 2023 · Checked Oct 3, 2026

The evidence and its limits

University of British Columbia and StatExpert Ltd · JAMA · 2023

Claims-record study of two GLP-1 drugs and gut diagnoses

Design:
Cohort
Participants:
5,411 users: 613 semaglutide, 4,144 liraglutide and 654 comparison-drug users
Finding:
The pooled GLP-1 group had higher rates of pancreatitis, bowel blockage and delayed stomach emptying than the comparison group.
Main limitation
Observational claims data, no body-mass-index data, and uncertainty about each person’s reason for use. It does not prove individual causation or risk for every GLP-1 drug.

Read the source: Claims-record study of two GLP-1 drugs and gut diagnoses (opens in a new tab) · Checked Oct 3, 2026

The short answer

Which drug records should I check first?
Keep the full drug name and the form you used. Save pharmacy and prescriber records with dates. Do not fill gaps with a product name from a headline. [5]
What does a company label establish?
A label can help you check a drug and company name. It does not prove what caused your harm. Ask who made your product at the time you used it. [14]
What do the court records say about company claims?
The GI case group includes claims against Novo Nordisk and others. Those claims are disputed. Common court work does not decide every patient’s lawsuit. [1]
What does the research prove about one user?
Research can raise questions for a claim review. It does not prove what caused your illness. A lawyer and clinician need the actual drug and medical history. [4]

What rules a case out

Not covered by this case

  • A brand name alone does not prove personal cause.
  • A current label is not your complete product history.
  • No firm acceptance or payment is promised.

The process

What happens next

  1. 01

    You answer a few questions

    About two minutes. Nothing is sent until you agree on the last step and press submit.

  2. 02

    A lawyer looks at it

    A lawyer at the firm reads your answers and checks them against the current case criteria.

  3. 03

    The firm decides and gets in touch

    If the firm takes your case, you get the terms in writing to read before you sign. You can always say no.

Checking a claim involving Novo Nordisk? Keep the exact drug name, form and dates. A current company label or lawsuit allegation does not prove who is liable for your injury.

Which drug records should I check first?

Keep the full drug name and the form you used. Save pharmacy and prescriber records with dates. Do not fill gaps with a product name from a headline.

The checked Ozempic injection label names semaglutide. DailyMed’s current Wegovy record also names semaglutide and shows both injection and tablet forms. Your own use must be confirmed from your records.

What does a company label establish?

A label can help you check a drug and company name. It does not prove what caused your harm. Ask who made your product at the time you used it.

The current Wegovy record identifies a Novo Nordisk packager. That current listing does not settle who made or supplied every earlier dose. Keep a box or label photo if you have one and ask the lawyer which records matter.

What do the court records say about company claims?

The GI case group includes claims against Novo Nordisk and others. Those claims are disputed. Common court work does not decide every patient’s lawsuit.

The court’s GI overview identifies allegations concerning named medicines and companies. The defendants deny the claims. A separate order created the NAION group; an eye claim must not be relabeled as a gut claim to match a company page.

What does the research prove about one user?

Research can raise questions for a claim review. It does not prove what caused your illness. A lawyer and clinician need the actual drug and medical history.

The 2023 Sodhi study abstract reports associations in selected claims-data comparisons of semaglutide and liraglutide users. Its design and record limits matter. The findings cannot establish a defect or liability for your particular product.

The FDA-hosted Ozempic injection label has specific safety warnings. A label warning and an individual court finding are different kinds of evidence.

How should I keep a useful timeline?

Write down use dates and dates of symptoms and care. Mark dates you do not know as unknown. Keep the original records instead of changing a diagnosis to match a claim page.

Request missing pharmacy and clinical files from covered providers where applicable. Keep a clear distinction between a symptom you recall and a diagnosis later recorded. The resulting timeline still needs individual review.

What should I ask before sending records?

Ask who will review the claim and receive your files. Check the personal time limit and written fee terms. A contact form does not start a court case.

Claim deadlines depend on the applicable facts and law. The ABA model fee rule is not a promise of a particular firm’s terms. Confirm the receiving firm’s current process before sharing sensitive files.

Scientific evidence for this case

Ozempic and GLP-1 gut injury claims · JAMA Ophthalmology · 2024Cohort

Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide

Type 2 diabetes patients: 8.9% NAION risk on semaglutide vs 1.8% on non-semaglutide medications

Ozempic and GLP-1 gut injury claims · JAMA · 2023Cohort

Risk of Gastrointestinal Adverse Events Associated With GLP-1 Receptor Agonists for Weight Loss

Gastroparesis hazard ratio: 3.67 (95% CI 1.15-11.90)

Ozempic and GLP-1 gut injury claims · Clinical Gastroenterology and Hepatology · 2024Meta-analysis

GLP-1 Receptor Agonists and Gallbladder Disease: A Systematic Review of Randomized Controlled Trials

37% increased relative risk of gallbladder disease across 76 RCTs

Find out where you stand.

The review is free and private. Asking for it doesn’t commit you to anything.

Register your interest

Sources

  1. Court GI case-group overviewCourt GI case-group overview · court
  2. August 28, 2026 GI hearing scheduleAugust 28, 2026 GI hearing schedule · court
  3. NAION transfer orderNAION transfer order · court
  4. Sodhi original gastrointestinal cohort studySodhi original gastrointestinal cohort study · study
  5. FDA Ozempic prescribing information, May 2026FDA Ozempic prescribing information, May 2026 · regulator
  6. NIDDK gastroparesis definitionNIDDK gastroparesis definition · regulator
  7. NIDDK gastroparesis diagnosisNIDDK gastroparesis diagnosis · regulator
  8. NIDDK symptoms and care warningsNIDDK symptoms and care warnings · regulator
  9. ABA Model Rule 1.5 fee questionsABA Model Rule 1.5 fee questions
  10. Court filing-time guideCourt filing-time guide · court
  11. Federal covered-record access ruleFederal covered-record access rule · regulator
  12. U.S. Courts civil-case guideU.S. Courts civil-case guide · court
  13. FDA Issues Class I Recall for Omnipod 5 Insulin Pods Over Leak Riskapi.fda.gov · Jul 14, 2026 · regulator
  14. DailyMed: Wegovy Product Label Identity

Checked against 14 primary sources by People's Justice editors · Updated

How we make money

People's Justice research team · Updated Oct 4, 2026